Asthma und Nasenop

Accreditation Statements

Physicians – This activity has been planned and
implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship of the American Academy of Allergy, Asthma and
Immunology (AAAAI) and National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health
(NIH). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians. The AAAAI
designates this activity for a maximum of 17.75 hours in Category 1 credit towards the AMA Physician’s Recognition
Award. Each physician should claim only those hours of credit he/she actually spends in this activity.

Nurses – This activity is provided by the Institute for Johns Hopkins Nursing, which is accredited
as a provider of continuing education in nursing by the American Nurses Credentialing Center’s Commission on
Accreditation. The Institutes for John Hopkins Nursing will provide 21 nursing credit hours.

Respiratory Therapists – The American Association for Respiratory Care will provide 16.75 hours of continuing education credits.

Pharmacists – The University of Florida College of Pharmacy is accredited by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. Statements of credits (12 hours) for pharmacists will be provided within 30 working days following completion of the program.

Health Educators – Sponsored by the National Heart, Lung, and Blood Institute, a designated multiple event provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is a designated event for the CHES to receive up to 21 Category I contact hours in health education.

Participant Learning Objectives

At the completion of the conference, participants will be able to:

• Implement strategies designed to significantly reduce asthma-related mortality and morbidity in all communities by the year 2010.
• Summarize recent asthma-related research with corresponding practical application.
• Identify clinical management practices, specifically new prevention, diagnosis, and treatment guidelines.
• Describe public health interventions to reduce the impact of asthma among different types of racial and ethnic populations and settings (e.g., school, workplace, community).
• Understand health care delivery trends and their impact on long-term asthma management, acute care, and prevention.
• Analyze past asthma-related interventions and weigh their value in today’s world.
• Implement health communication strategies and know how to more effectively reach target populations and raise awareness.
• Summarize asthma data, including mortality, morbidity, and risk factor prevalence.
• Create networking opportunities and build partnerships with key asthma researchers, clinicians, and prevention professionals.